Compare Stocks

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$0.93 -2.5%	$1.23	$0.92 ▼ $2.55	$1.99B	1.36	22.41 million shs	1.39 million shs
EIHDF 888	$1.04	$1.09	$0.87 ▼ $1.63	N/A	N/A	16,500 shs	926 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	-5.73%	-14.61%	-11.84%	-21.64%	-26.76%
EIHDF 888	-2.20%	-3.13%	-4.05%	-0.28%	+4.88%

Trump’s “Tax Free” Retirement Strategy (Ad)

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DNA Ginkgo Bioworks	1.2959 of 5 stars	3.0	0.0	0.0	0.0	2.4	3.3	0.6
EIHDF 888	0.6246 of 5 stars	0.0	2.0	1.7	0.0	2.7	0.0	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNA Ginkgo Bioworks	2.00	Hold	$2.20	137.58% Upside
EIHDF 888	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest SGR, EIHDF, CWN, and DNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/1/2024	DNA Ginkgo Bioworks	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$7.00 ➝ $3.00
1/22/2024	DNA Ginkgo Bioworks	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sell ➝ Sell	$1.25 ➝ $1.10

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNA Ginkgo Bioworks	$251.46M	7.93	N/A	N/A	$0.55 per share	1.68
EIHDF 888	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNA Ginkgo Bioworks	-$892.87M	-$0.47	N/A	N/A	N/A	-355.08%	-48.23%	-31.35%	5/8/2024 (Estimated)
EIHDF 888	N/A	$0.14	7.67	∞	N/A	N/A	N/A	N/A	N/A

Latest SGR, EIHDF, CWN, and DNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	12/31/2023	DNA Ginkgo Bioworks	-$0.09	-$0.10	-$0.01	-$0.07	$40.37 million	$34.76 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
EIHDF 888	$0.14	13.46%	N/A	103.21%	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNA Ginkgo Bioworks	N/A	6.11	6.11
EIHDF 888	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DNA Ginkgo Bioworks	78.63%
EIHDF 888	14.77%

Insider Ownership

Company	Insider Ownership
DNA Ginkgo Bioworks	15.05%
EIHDF 888	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DNA Ginkgo Bioworks	1,218	2.15 billion	1.83 billion	Optionable
EIHDF 888	11,000	N/A	N/A	Not Optionable

SGR, EIHDF, CWN, and DNA Headlines

Source	Headline
	888 (OTCMKTS:EIHDF) Shares Pass Below 50-Day Moving Average of $1.09 americanbankingnews.com - April 11 at 4:38 AM
	888 Holdings plc (EIHDF) Q4 2023 Earnings Call Transcript seekingalpha.com - March 28 at 6:24 PM
	888 Holdings sells assets to Hard Rock in US exit proactiveinvestors.co.uk - March 28 at 4:55 AM
	William Hill owner 888 Holdings' new top team set to update strategy - was 2023 just a dream? proactiveinvestors.co.uk - March 21 at 10:32 AM
	UPDATE 1-888 ends Sports Illustrated deal as intense US competition sparks review msn.com - March 6 at 5:35 PM
	888 Holdings mulls sale of US business proactiveinvestors.co.uk - March 6 at 3:11 AM
	888 Holdings plc (888.L) finance.yahoo.com - January 31 at 4:13 AM
	888 Holdings PLC EIHDF morningstar.com - December 1 at 1:00 PM
	Morning Brew: AMC Plummets on Stock Offering, Disney Surges on Earnings finance.yahoo.com - November 9 at 2:45 PM
	DraftKings discussed bid for William Hill owner 888 over the summer - report msn.com - November 9 at 9:45 AM
	888 Holdings (888) uk.investing.com - August 11 at 7:00 PM
	EIHDF 888 Holdings plc seekingalpha.com - June 15 at 12:34 PM
	Benzinga Names 888 Holdings A 'Challenger' Award Recipient At Inaugural Titans Sports Betting Event benzinga.com - May 24 at 3:29 PM
	Wash Heights Restaurant Openings: Lobster Steakhouse, 888 Hudson Thai patch.com - April 16 at 9:51 AM
	888 Holdings plummets after being rocked up money laundering scandal, CEO resignation msn.com - January 31 at 9:42 AM
	European Stocks Mixed as Betting Companies Make Deals thestreet.com - January 14 at 2:05 PM
	7 Best Penny Stocks Under $3 to Buy msn.com - December 2 at 2:37 PM
	888 Holdings highlights upside from William Hill deal seekingalpha.com - November 30 at 2:59 PM
	Entain and European sports betting peers look for World Cup bounce seekingalpha.com - October 17 at 12:50 PM
	Best Snapdragon 888 Phones in India (2022) digit.in - September 10 at 12:04 AM
	888 Holdings plc (EIHDF) CEO Itai Pazner on Q2 2022 Results - Earnings Call Transcript seekingalpha.com - August 12 at 11:44 PM
	888 Holdings faces challenges with William Hill absorption seekingalpha.com - July 5 at 8:09 AM
	Why quality and value might be key drivers of the 888 Holdings share price uk.finance.yahoo.com - May 24 at 7:09 PM
	British gambling firm 888 Holdings' annual profit triples on online boom uk.finance.yahoo.com - March 10 at 8:45 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ginkgo Bioworks

NYSE:DNA

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

888

OTCMKTS:EIHDF

888 Holdings plc, together with its subsidiaries, provides online betting and gaming products and solutions in the United Kingdom, Italy, Spain, and internationally. It operates through three segments Retail, UK Online, and International. The company engages in the operation of gaming machines; and sports betting, casino, poker, and other gaming products, as well as offers telephone betting services. The company owns and operates its business through William Hill, 888casino, 888poker, 888sport, Mr Green, SI Casino, and SI Sportsbook brands. 888 Holdings plc was founded in 1997 and is headquartered in Gibraltar, Gibraltar.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial